European Journal of Clinical Pharmacology

, Volume 28, Issue 6, pp 631–636 | Cite as

Bronchorelaxation and plasma histamine after salbutamol inhalation

  • I. Macquin
  • A. Harf
  • F. Zerah
  • C. Sabatier
  • F. Lhoste


Plasma histamine in 8 normal subjects was measured before and after inhalation of carbachol to induce a 50% fall in specific airway conductance (SGaw). The measurements were repeated 5 min after inhalation of salbutamol or placebo. No significant change in plasma histamine occurred after placebo or carbachol inhalation, despite the persistent induced bronchospasm after the latter treatment. In contrast, plasma histamine was significantly increased from 0.25 to 0.43 ng/ml after salbutamol inhalation. Simultaneously, induced bronchospasm was relieved, from 51% to 103% of baseline SGaw. Thus, the relief of carbachol-induced bronchospasm by salbutamol was associated with a rise in plasma histamine. Since salbutamol itself is a potent inhibitor of mast cell degranulation and histamine release, the present findings suggest that histamine may be released and sequestered within the lungs during carbachol-induced-bronchospasm, and also that desequestration of bronchoconstrictor mediators accumulated at the point of contact of bronchial smooth muscle may contribute to the relief of bronchospasm by salbutamol.

Key words

salbutamol histamine plasma concentration bronchorelaxation healthy volunteers induced bronchoconstriction carbachol bronchoconstrictor mediators 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Austen KF, Orange RP (1975) Bronchial asthma: The possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis 112: 423–436Google Scholar
  2. 2.
    Hirshman CA, Peters J, Butler J, Hanifin JM, Downes H (1983) Role of mediators in allergic and nonallergic asthma in dogs with hyperreactive airways. J Appl Physiol: Respir Environ Exercise Physiol 54: 1108–1114Google Scholar
  3. 3.
    Brown MJ, Ind PW, Causon R, Lee Th (1982) A novel double-isotope technique for the enzymatic assay of plasma histamine: Application to estimation of mast cell activation assessed by antigen challenge in asthmatics. J Allergy Clin Immunol 69: 20–24Google Scholar
  4. 4.
    Bhat KN, Arroyave CM, Marney SR, Stevenson DD, Tan EM (1977) Plasma histamine changes during provoked bronchospasm in asthmatic patients. J Allergy Clin Immunol 58: 647–656Google Scholar
  5. 5.
    Lee TH, Brown MJ, Nagy L, Causon R, Walport MJ, Kay AB (1982) Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics. J Allergy Clin Immunol 70: 73–81Google Scholar
  6. 6.
    Allen DH, Mathison DA, Wagner PD, Arroyave CM, Plow E, Tan EM (1978) Mediator release during methacholine-induced bronchoconstriction in asthmatic patients. J Allergy Clin Immunol 61: 140Google Scholar
  7. 7.
    Atkins PC, Rosenblum F, Dunsky EH, Coffey EH, Zweiman B (1980) Comparison of plasma histamine and cyclic nucleotides after antigen and methacholine inhalation in man. J Allergy Clin Immunol 66: 478–485Google Scholar
  8. 8.
    Macquin I, Zerah F, Harf A, Sabatier C, Lhoste F (1984) Plasma histamine and catecholamines during carbachol-induced bronchoconstriction in normal subjects. J Allergy Clin Immunol 74: 291–295Google Scholar
  9. 9.
    Orehek J, Massari JP, Gayrard P, Grimaud C, Charpin J (1976) Effect of short-term, low-level nitrogen dioxide exposure on bronchial sensitivity of asthmatic patients. J Clin Invest 57: 301–307Google Scholar
  10. 10.
    Harf A, Atlan G, Lorino H, Deshayes S, Morin C, Laurent D (1981) Correction for non linearity of body flow plethysmograph. J Appl Physiol: Respir Environ Exercise Physiol 50: 658–662Google Scholar
  11. 11.
    Dubois AB, Botelho AB, Comroe JH (1956) A new method for measuring airway resistance in man using a body plethysmograph: Values in normal subjects and in patients with respiratory disease. J Clin Invest 35: 327–333Google Scholar
  12. 12.
    Orehek J, Gayrard P, Smith AP, Grimaud C, Charpin J (1977) Airway response to carbachol in normal and asthmatic subjects. Am Rev Respir Dis 115: 937–943Google Scholar
  13. 13.
    Shaff RE, Beaven MA (1979) Increased sensitivity of the enzymatic isotopic assay of histamine: Measurement of histamine in plasma and serum. Anal Biochem 94: 425–430Google Scholar
  14. 14.
    Snedecor GW, Cochran WG (1957) Statistical methods (6th edn). Iowa State University Press, Ames, IowaGoogle Scholar
  15. 15.
    Dyer J, Warren K, Merlin S, Metcalfe DD, Kaliner M (1982) Measurement of plasma histamine: Description of an improved method and normal values. J Allergy Clin Immunol 70: 82–87Google Scholar
  16. 16.
    Lorenz W, Reimann HJ, Barth H, Kusche J, Meyer R, Doenicke A, Hutzel M (1972) A sensitive and specific method for the determination of histamine in human whole blood and plasma. Hoppe-Syler's Z Physiol Chem 353: 911–920Google Scholar
  17. 17.
    Lorenz W, Neugebauer E, Schmal A (1982) Le dosage de l'histamine plasmatique lors de reactions anaphylactoïdes chez le sujet anesthésié. Ann Fr Anesth Reanim 1: 271–276Google Scholar
  18. 18.
    Butchers PR, Fullarton JR, Skidmore IF, Thompson LE, Vardey CJ, Wheeldon A (1979) A comparison of the antianaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue. Br J Pharmacol 67: 23–32Google Scholar
  19. 19.
    Church MK, Young KD (1983) The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. Br J Pharmacol 78: 671–679Google Scholar
  20. 20.
    Gold WM (1980) Interactions between mast cells, mediators and nerves. In: Hargreave FE (ed). Airway reactivity: Mechanisms and clinical relevance. Astra Pharmaceuticals Canada Ltd, Mississauga, pp 160–170Google Scholar
  21. 21.
    Martin GL, Atkins PC, Dunsky EH, Zweiman B (1980) Effects of theophylline, terbutaline, and prednisone on antigen induced bronchospasm and mediator release. J Allergy Clin Immunol 66: 204–212Google Scholar
  22. 22.
    Jack D, Harris DM, Middleton E Jr (1978) Adrenergic agents. In: Middleton E Jr, Reed CE, Ellis EF (eds). Allergy: Principles and practice, vol 1. CV Mosby, Saint Louis, pp 407–427Google Scholar
  23. 23.
    Anderson SD, Seale JP, Rozea P, Bandler L, Theobald G, Linsay DA (1976) Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis 114: 493–500Google Scholar
  24. 24.
    Godfrey S (1975) Exercise-induced asthma: Clinical, physiological and therapeutic implications. J Allergy Clin Immunol 56: 1–17Google Scholar
  25. 25.
    Fantozzi R, Masini E, Blandina P, Mannaioni PF, Bani-Sacchi T (1978) Release of histamine from rat mast cells by acetylcholine. Nature 273: 473–474Google Scholar
  26. 26.
    Kaliner M, Orange RP, Austen KF (1972) Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. IV: Enhancement by cholinergic and alpha adrenergic stimulation. J Exp Med 136: 556–567Google Scholar
  27. 27.
    Kazimierczak W, Adamas B, Másliński C (1980) Failure of acetylcholine to release histamine from rat mast cells. Agents Actions 10 (1 pt 2): 1–3Google Scholar
  28. 28.
    Heckscher T, Bass H, Oriol A, Rose B, Anthonisen NR, Bates DV (1968) Regional lung function in patients with bronchial asthma. J Clin Invest 47: 1063–1070Google Scholar
  29. 29.
    Wagner PD, Dantzker DR, Iacovoni VE, Tomlin WC, West JB (1978) Ventilation-perfusion inequality in asymptomatic asthma. Am Rev Respir Dis 118: 511–524Google Scholar
  30. 30.
    Raine JM, Bishop JM (1964) Alterations in ventilation-perfusion relationships in the lung after breathing inert dust or bronchoconstrictor aerosols and after short periods of voluntary hyperventilation. J Clin Invest 43: 557–570Google Scholar
  31. 31.
    Olive JT, Hyatt RE (1972) Maximal expiratory flow and total respiratory resistance during induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 106: 366–376Google Scholar
  32. 32.
    Permutt S (1975) Physiological changes in the acute asthmatic attack. In: Austen KF, Lichenstein LM (eds). Asthma. Academic Press, New York, pp 15–27Google Scholar
  33. 33.
    Culver GH, Butler J (1980) Mechanical influences on the pulmonary microcirculation. Ann Rev Physiol 42: 187–198Google Scholar
  34. 34.
    Hakim TS, Michel RP, Chang HK (1982) Effect of lung inflation on pulmonary vascular resistance by arterial and venous occlusion. J Appl Physiol: Respir Environ Exercise Physiol 53: 1110–1115Google Scholar
  35. 35.
    Bergofsky EH (1980) Humoral control of the pulmonary circulation. Ann Rev Physiol 42: 221–233Google Scholar
  36. 36.
    Kadowitz PJ, Hyman AL (1983) Pulmonary vascular responses to histamine in sheep. Am J Physiol 244 (Heart Circ Physiol 13): H423-H428Google Scholar
  37. 37.
    Dawson CA, Bronikowski TA, Lineham JH, Hakim TS (1983) Influence of pulmonary vasoconstriction on lung water and perfusion heterogeneity. J Appl Physiol: Respir Environ Exercise Physiol 54: 654–660Google Scholar
  38. 38.
    Brittain RT, Dean CM, Jack D (1981) Sympathomimetic bronchodilator drugs. In: Widdicombe JG (ed). Respiratory pharmacology. Pergamon, Oxford, pp 613–655Google Scholar
  39. 39.
    Chapman KR, Smith DL, Rebuck AS, Leenen FHH (1984) Hemodynamic effects of an inhaled beta2-agonist. Clin Pharmacol Ther 35: 762–767Google Scholar
  40. 40.
    Kelly L, Conway C, Gertner A, Spannhake E, Menkes H, Bromberger-Barnea B (1983) Influence of blood flow on the duration of histamine-induced responses in the lung periphery. Fed Proc 42: 1094Google Scholar
  41. 41.
    Quanjerph H, Dalhuijsen A, Van Zomeren BC (1983) Summary equations of reference values. Bull Europ Physiopathol Respir 19 [Suppl 5]: 45–51Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • I. Macquin
    • 1
  • A. Harf
    • 2
  • F. Zerah
    • 2
  • C. Sabatier
    • 1
  • F. Lhoste
    • 1
  1. 1.Département de Pharmacologie CliniqueHôpital Henri MondorCréteilFrance
  2. 2.Laboratoire de Physiologie et Unité U 138, Institut National de la Santé et de la Recherche MédicaleHôpital Henri MondorCréteilFrance

Personalised recommendations